Thus inactivation of Bad and Bim through MAPK phosphorylation as well as downregulation of PUMA and upregulation of Mcl-1 by MAPKs can be assumed as contributing to melanoma cell survival and chemoresistance [98-100]. This evidence concerns the gene BCL2L11 and melanoma.